S32006

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2016
012320082016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The antidepressive drug agomelatine combines the properties of an agonist of melatonergic receptors 1 and 2 with an antagonist of… (More)
Is this relevant?
2014
2014
Depression and biological rhythms disturbances are strongly associated. Agomelatine is an antidepressant with melatoninergic MT1… (More)
Is this relevant?
2012
2012
The novel melatonergic agonist/5-HT(2C) antagonist agomelatine displays robust antidepressant properties in humans and is active… (More)
Is this relevant?
2012
2012
Serotonin(2C) receptors (5-HT(2)C) exert continuous control on the activity of specific populations of neurons in the basal… (More)
Is this relevant?
2011
2011
The novel antidepressant, agomelatine, behaves as an agonist at melatonergic receptors, and as an antagonist at edited, human… (More)
Is this relevant?
2010
2010
OBJECTIVES The aim of this study was to investigate the acute modulation of the neurotrophin Brain-derived neurotrophic factor… (More)
Is this relevant?
2010
2010
Agomelatine is a melatonergic receptor agonist and a 5HT2C receptor antagonist that has shown antidepressant efficacy. In order… (More)
  • figure 1
Is this relevant?
2009
2009
Agomelatine is a novel antidepressant acting as a melatonergic receptor agonist and serotonergic (5-HT2C) receptor antagonist. In… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
The novel antidepressant, agomelatine, behaves as an agonist at melatonin MT1 and MT2 receptors and as an antagonist at serotonin… (More)
Is this relevant?
2008
2008
Serotonin (5-HT)2C receptors are implicated in the control of mood, and their blockade is of potential interest for the… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?